Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Kimball International, Inc. (“Kimball” or the “Company”) (NasdaqGS: KBALB) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval for the amendment and restatement to the Company’s 2003 Stock Option and Incentive Plan (“Plan”). Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on September 4, 2013, the Board of Directors recommends that Kimballs’ shareholders vote to approve an amendment and restatement to the Plan to increase the number of shares available for issuance pursuant to all awards thereunder from 2,500,000 to 5,000,000 shares. This Plan also seeks to increase shares for issuance pursuant to incentive stock options from 2,500,000 to 5,000,000. The issuance of the additional shares could have a substantial dilutive effect on the shares of Kimball common stock. Request more information now by clicking here: www.faruqilaw.com/KBALB. There is no cost or obligation to you.Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. If you own common stock in Kimball and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/KBALB or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.